Showing results 8 to 11 of 11
Issue Date | Title | Author(s) | Type |
---|---|---|---|
2022 | Korean Guidelines for Pharmacoeconomic Evaluations: Updates in the Third Version | 배승진 | Article |
2017 | Potent osteogenic activity of a novel imidazobenzimidazole derivative, IBIP | 황은숙 | Article |
2012 | TAZ is required for the osteogenic and anti-adipogenic activities of kaempferol | 황은숙 | Article |
2022 | The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS | 배승진 | Article |